Azenta, Inc. (AZTA)
NASDAQ: AZTA · IEX Real-Time Price · USD
-1.92 (-3.36%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Azenta Revenue

Azenta had revenue of $651.76M in the twelve months ending March 31, 2024, with 9.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $159.13M with 7.23% year-over-year growth. In the fiscal year ending September 30, 2023, Azenta had annual revenue of $665.07M with 19.73% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
2.98B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Sep 30, 2023665.07M109.57M19.73%
Sep 30, 2022555.50M41.80M8.14%
Sep 30, 2021513.70M125.17M32.21%
Sep 30, 2020388.54M-392.31M-50.24%
Sep 30, 2019780.85M149.29M23.64%
Sep 30, 2018631.56M104.06M19.73%
Sep 30, 2017527.50M93.49M21.54%
Sep 30, 2016434.01M-118.70M-21.48%
Sep 30, 2015552.71M69.86M14.47%
Sep 30, 2014482.85M60.41M14.30%
Sep 30, 2013422.44M-66.54M-13.61%
Sep 30, 2012488.98M-199.12M-28.94%
Sep 30, 2011688.11M95.13M16.04%
Sep 30, 2010592.97M374.27M171.13%
Sep 30, 2009218.71M-307.66M-58.45%
Sep 30, 2008526.37M-216.89M-29.18%
Sep 30, 2007743.26M135.76M22.35%
Sep 30, 2006607.49M237.72M64.29%
Sep 30, 2005369.78M-165.28M-30.89%
Sep 30, 2004535.05M194.96M57.33%
Sep 30, 2003340.09M35.84M11.78%
Sep 30, 2002304.25M-77.46M-20.29%
Sep 30, 2001381.72M44.53M13.21%
Sep 30, 2000337.18M214.23M174.23%
Sep 30, 1999122.96M5.67M4.83%
Sep 30, 1998117.29M7.86M7.19%
Sep 30, 1997109.43M-3.30M-2.93%
Sep 30, 1996112.73M61.77M121.22%
Sep 30, 199550.96M24.31M91.20%
Sep 30, 199426.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LivaNova 1.19B
ACADIA Pharmaceuticals 813.81M
Tandem Diabetes Care 770.01M
GoodRx Holdings 764.16M
iRhythm Technologies 513.17M
ADMA Biologics 283.18M
Geron 520.00K
Revenue Rankings